Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million in cash to gain access to its lead drug ...

It was bought new by the founder of Hawaiian Tropic, who quite obviously was living the Good Life in the '80s.

At the heart of the deal is the drug candidate dordaviprone, which is months away from a regulatory verdict for its use in H3 ...